Sarcomatoid Mesothelioma
If you have been diagnosed with Mesothelioma or Lung Cancer you could be entitled to significant compensation from both the Asbestos Trust Funds and asbestos product manufactures.
Contact us now for a FREE consultation.
- Find Out if you are Eligible
- Determine How Much Your Case is Worth
- Receive a Free Mesothelioma Consultation
Free Case Review
Sarcomatoid Mesothelioma
If you have been diagnosed with Mesothelioma or Lung Cancer you could be entitled to significant compensation from both the Asbestos Trust Funds and asbestos product manufactures.
Contact us now for a FREE consultation.
- FREE Case Review – Find out if you qualify for compensation.
- Millions Won for Mesothelioma Victims – Proven results for asbestos exposure cases.
- No Upfront Costs – You only pay if we win your case.
Free Case Review
What is Sarcomatoid Mesothelioma?
Sarcomatoid mesothelioma is the rarest and, at the same time, the most aggressive form of malignant mesothelioma, a cancer caused by asbestos exposure.
It can develop in the lining of the lung, abdomen, or heart, though it most often affects the pleura (the lining of the lungs).
This mesothelioma type is characterized by spindle-shaped cells.
Because it lacks a defined structure and spreads rapidly, it is more challenging to treat than other forms of the disease.
Unlike epithelioid mesothelioma, which has cells that cluster together, sarcomatoid cells are loosely arranged, allowing them to migrate and invade surrounding tissues more easily.
This aggressive nature leads to a poorer prognosis compared to other mesothelioma subtypes, with shorter survival times and fewer treatment options.
Sarcomatoid mesothelioma accounts for approximately 10-20% of all mesothelioma cases. While rare, its aggressive nature makes it a particularly challenging form of the disease. Most cases occur in individuals with a history of prolonged asbestos exposure, such as construction workers, shipyard employees, industrial laborers, and veterans.
Men are significantly more likely to develop sarcomatoid mesothelioma than women, primarily due to occupational exposure risks in industries where asbestos was heavily used. The disease is also more common in older adults, as mesothelioma has a long latency period—often taking 20 to 50 years to develop after the person’s initial asbestos exposure.
Because sarcomatoid mesothelioma is difficult to diagnose and often mistaken for other conditions, early detection is critical. If you or a loved one has been diagnosed with this rare form of mesothelioma, legal and medical options may be available to help you seek compensation and access specialized treatment.
Types of Mesothelioma
Mesothelioma comes in a few different forms, and the type someone is diagnosed with can make a big difference in treatment options and prognosis.
The three main types are epithelioid, biphasic, and sarcomatoid mesothelioma—with sarcomatoid being the rarest and most aggressive.
Epithelioid mesothelioma is the most common subtype, making up about 50-70% of all cases. This type develops from epithelial cells, which tend to grow in clusters.
The structured nature of these cells means they spread more slowly than other types, making epithelioid mesothelioma the most treatable form.
Patients with epithelioid mesothelioma generally have better survival rates compared to those with other subtypes.
Because the cells stick together, they’re easier to remove through surgery, and chemotherapy tends to be more effective.
While still a serious diagnosis, those with this type of mesothelioma often respond better to treatment.
Biphasic mesothelioma is a combination of epithelioid and sarcomatoid cells, meaning it shares characteristics of both.
The prognosis depends on the ratio of these cell types—if there are more epithelioid cells, treatment may be more effective; if there are more sarcomatoid cells, the disease is likely to be more aggressive.
Because biphasic mesothelioma has mixed-cell behavior, treatment can be unpredictable, and doctors often customize treatment plans based on the specific cell makeup
As mentioned, sarcomatoid malignant mesothelioma is the rarest and most aggressive form, accounting for 10-20% of all cases.
Unlike epithelioid cells, sarcomatoid cells are spindle-shaped, loosely structured, and can spread rapidly throughout the body.
This makes them resistant to many standard treatments.
Since sarcomatoid mesothelioma is harder to treat, early detection is crucial. Unfortunately, because it’s often misdiagnosed, it can be difficult to catch in its earlier stages.
While treatment options are more limited, ongoing research into immunotherapy and targeted therapies is offering new hope for those with this form of mesothelioma.
Causes and Risk Factors
The number one cause of sarcomatoid mesothelioma is asbestos exposure.
Asbestos, a natural mineral, was once widely used in construction, shipbuilding, manufacturing, and other industries due to its heat-resistant and insulating properties.
The problem is that when asbestos fibers are disturbed, they can get airborne and, if inhaled or ingested, embed themselves in the lining of the lungs, abdomen, or heart.
Once inside the body, these tiny, needle-like fibers trigger inflammation and DNA damage, leading to cellular mutations that can eventually develop into cancer.
The latency period is incredibly long—mesothelioma can take from 20 to 50 years to develop after asbestos exposure.
Even if you didn’t work directly with asbestos, you could still be at risk due to secondary exposure.
Many workers unknowingly carried asbestos fibers home on their clothing, hair, and skin, exposing their family members in the process.
For example, spouses who washed their partner’s work clothes often inhaled asbestos dust, putting them at risk for mesothelioma decades later.
Children exposed through their parents’ work uniforms also faced the same dangers.
Unfortunately, this means that people who never set foot on a job site where asbestos was used can still develop asbestos-related diseases.
While being exposed to asbestos is the main cause of sarcomatoid mesothelioma, some people are more genetically susceptible than others.
Studies show that mutations in the BAP1 gene (a tumor-suppressing gene) can increase the risk of developing mesothelioma.
People with this genetic mutation may be more vulnerable to asbestos exposure, even at lower levels.
Beyond occupational exposure, environmental asbestos exposure can also be a risk.
Certain areas have natural asbestos deposits, and people living near old asbestos mines or factories may develop mesothelioma simply from breathing in contaminated air.
This underscores the importance of asbestos awareness and proper removal procedures to prevent exposure-related diseases
Symptoms of Sarcomatoid Mesothelioma
Sarcomatoid mesothelioma is aggressive and often goes unnoticed in its early stages because its symptoms can mimic common respiratory conditions.
Unfortunately, this can lead to delayed diagnosis, making treatment more challenging.
However, recognizing the symptoms early and seeking medical attention from a specialist who’s familiar with mesothelioma can greatly improve the likelihood of getting the right care.
At first, symptoms of sarcomatoid mesothelioma may seem mild or nonspecific, making them easy to overlook.
Some of the most common early warning signs of malignant pleural mesothelioma include:
Persistent cough that doesn’t go away
Chest pain or tightness
Shortness of breath, even with light activity
Mild fatigue or feeling more tired than usual
Unexplained weight loss, even without making any changes in diet or exercise
Because these symptoms develop gradually, many patients with sarcomatoid mesothelioma dismiss them as minor issues or associate them with aging, smoking history, or another common respiratory condition.
As pleural sarcomatoid mesothelioma progresses, symptoms become more severe and debilitating due to the cancer spreading throughout the body.
Advanced symptoms include:
Severe difficulty breathing due to mesothelioma tumor growth
Respiratory failure, as lung function declines
Extreme fatigue that makes daily activities difficult
Fluid buildup (pleural effusion) in the chest, causing pain and additional breathing problems
Sarcomatoid patients may have systemic complications, such as widespread inflammation and weakened immune function.
At this stage, many people experience a decline in their quality of life, and treatment often focuses on managing symptoms and improving comfort.
Because peritoneal mesothelioma affects a different part of the body, its symptoms may differ somewhat. However, it is not common.
Pleural mesothelioma that affects the lining of the lungs is much more common than peritoneal sarcomatoid mesothelioma.
One of the biggest challenges with sarcomatoid mesothelioma is that it’s frequently misdiagnosed.
Because its symptoms are similar to those of COPD, pneumonia, chronic bronchitis, or even lung cancer, many patients go through multiple rounds of testing before getting an accurate diagnosis.
Seeing a mesothelioma specialist is crucial.
These experts use advanced imaging tests and biopsies to confirm the diagnosis and determine the best course of action.
If you or a loved one is experiencing persistent respiratory issues and has a history of asbestos exposure, don’t hesitate to seek a second opinion from a specialist mesothelioma doctor
Diagnosis of Sarcomatoid Mesothelioma
Diagnosing sarcomatoid mesothelioma is challenging because it’s a rare and aggressive cancer that often mimics other conditions.
Since symptoms like chronic cough, chest pain, and shortness of breath can be mistaken for other respiratory diseases, multiple tests are needed to confirm the diagnosis.
A proper diagnosis usually involves imaging scans, biopsies of the sarcomatoid mesothelioma cells, and histopathological analysis to distinguish sarcomatoid mesothelioma from other cancers.
Doctors start with imaging tests to look for abnormalities, locate tumors, and assess how far the cancer has spread. The most common scans include:
CT Scans (Computed Tomography)
The first-line imaging test for detecting sarcomatoid mesothelioma.
It helps identify tumor size and location and spread it to nearby organs.
In sarcomatoid mesothelioma, CT scans often show an irregular, thickened pleural lining and significant tumor growth.
PET Scans (Positron Emission Tomography)
Used to detect metastasis (cancer spreading beyond the lungs).
Highlights areas with high metabolic activity, which often indicates cancerous growth.
Helps doctors determine if the disease has moved into the lymph nodes or distant organs.
While imaging tests can strongly suggest mesothelioma, a biopsy is required for a definitive diagnosis.
This involves removing a tissue sample and examining it under a microscope.
Needle Biopsy (Fine Needle Aspiration – FNA)
A less invasive option, where a needle extracts a small tissue sample.
It is often used when tumors are easily accessible, but it may not always provide enough tissue for an accurate diagnosis.
Surgical Biopsy (Thoracoscopy or Open Biopsy)
A more comprehensive biopsy method that allows doctors to collect a larger tissue sample.
Often necessary for sarcomatoid mesothelioma, as it provides a clearer picture of the cancer’s structure.
Once a biopsy is taken, pathologists examine the sample to confirm if the tumor consists of sarcomatoid cells.
These spindle-shaped cells lack a defined structure and spread rapidly, making them distinct from the more structured epithelioid cells seen in other mesothelioma types.
Since sarcomatoid mesothelioma is rare, it’s sometimes mistaken for other aggressive cancers like sarcomas or lung cancer.
Special staining techniques and molecular testing help distinguish it from similar-looking conditions.
Because sarcomatoid mesothelioma shares symptoms with other lung diseases, misdiagnosis is common.
The cancer’s aggressive and fast-spreading nature also means that by the time it’s identified, it’s often in an advanced stage.
To avoid delays, seeking a specialist familiar with mesothelioma is essential.
If you or a loved one has a history of asbestos exposure and unexplained respiratory symptoms, it’s important to push for further testing and a second opinion if needed.
Staging of Sarcomatoid Mesothelioma
Like other cancers, sarcomatoid mesothelioma is classified into four stages based on how far it has spread.
Staging helps doctors determine prognosis and treatment options, though sarcomatoid mesothelioma is often diagnosed at a later stage due to its aggressive nature.
Sarcomatoid mesothelioma follows the same TNM staging system used for pleural mesothelioma, which considers tumor size (T), lymph node involvement (N), and metastasis (M).
Stage I – The tumor is localized to the pleura (lung lining) and has not spread to lymph nodes or other organs. Symptoms are mild, and treatment options like surgery may still be effective.
Stage II – The cancer has at this point spread to nearby lymph nodes but remains contained within the pleura. Symptoms may become more noticeable, including chest pain and shortness of breath.
Stage III – Tumors have spread to surrounding tissues, such as the diaphragm or chest wall. Treatment options become more limited, and aggressive therapies like chemotherapy and immunotherapy are often recommended.
Stage IV – The cancer has metastasized, meaning it has spread to distant organs, such as the liver, bones, or other organs. At this stage, treatment usually focuses on managing symptoms and improving overall quality of life instead of curative approaches.
The earlier sarcomatoid mesothelioma is diagnosed, the better the chances of longer survival.
However, because this type is highly aggressive, survival rates remain lower than for other mesothelioma types.
Stage I & II patients may have more treatment options, including surgery, chemotherapy, and emerging therapies like immunotherapy.
Stage III & IV patients often focus on palliative care, as the cancer is harder to control.
Regardless of the stage, it is crucial to seek care from a mesothelioma specialist.
They can build a personalized treatment plan to maximize quality of life and explore cutting-edge therapies.
Sarcomatoid Mesothelioma Treatment Options
Since sarcomatoid mesothelioma is the most aggressive form of mesothelioma, it makes treatment more challenging.
Because the spindle-shaped cells spread rapidly and are often resistant to treatment, a multidisciplinary approach is usually needed to treat the sarcomatoid subtype and extend patient survival.
While there is no cure, treatment can help slow the progression of the disease, manage the symptoms, and improve the quality of life despite the overall poor prognosis of sarcomatoid mesothelioma.
The general goals are to extend the patient’s life expectancy and make the patient more comfortable.
Surgery is an option for some patients, but because sarcomatoid mesothelioma is often diagnosed in later stages, not everyone is a candidate.
The goal is to remove as much of the tumor as possible and, in some cases, affected organs or tissue.
Pleurectomy/Decortication (P/D): This procedure removes the tumor from the lung lining (pleura) without removing the entire lung. It’s a lung-sparing surgery that can help reduce symptoms and slow the disease’s progression.
Extrapleural Pneumonectomy (EPP) is a more radical approach that involves removing an entire lung, the diaphragm, and part of the pericardium (heart lining). Because sarcomatoid mesothelioma spreads aggressively, this surgery is less commonly recommended than for epithelioid mesothelioma.
Chemotherapy is the most widely used treatment for sarcomatoid mesothelioma cancer.
Since surgery alone cannot eliminate all cancer cells, chemotherapy is frequently used to shrink tumors and slow their spread.
The standard chemotherapy regimen includes pemetrexed (Alimta) and cisplatin. This combination can extend survival and improve quality of life.
Some patients receive combination therapies, where chemotherapy is used alongside other treatments, such as immunotherapy or radiation therapy, to increase effectiveness.
While chemotherapy can effectively slow tumor growth, sarcomatoid cells tend to be more resistant than epithelioid cells, resulting in lower response rates
Radiation therapy is not very often used as a primary treatment for sarcomatoid mesothelioma because the cancer does not respond well to it.
However, palliative radiation can help manage pain and discomfort, especially if the tumor is pressing on the lungs, nerves, or other organs.
It can reduce chest pain, breathing difficulties, and pleural effusion buildup.
It is sometimes used after surgery to eliminate any remaining cancer cells.
Because standard treatments don’t always work well for sarcomatoid mesothelioma, researchers are exploring newer therapies that may offer better results.
Immunotherapy—Checkpoint inhibitors like Keytruda (pembrolizumab) and Opdivo (nivolumab) are promising in boosting the immune system to fight cancer. Clinical trials suggest that some sarcomatoid mesothelioma patients respond well to these drugs, potentially improving survival.
Gene Therapy – Scientists are investigating ways to target genetic mutations in mesothelioma cells to stop their growth. While still in the experimental stage, gene therapy could lead to breakthroughs in treatment in the coming years.
Because sarcomatoid mesothelioma is so aggressive, treatment is most effective when a team of specialists is involved. A multidisciplinary approach typically includes:
Oncologists (cancer doctors) who determine chemotherapy and immunotherapy options.
Surgeons evaluate whether surgery is possible.
Radiologists assess tumor growth and spread.
Palliative care specialists focus on helping to manage symptoms and quality of life.
Since every case of sarcomatoid mesothelioma is different, personalized treatment plans are critical.
Seeking care from a mesothelioma specialist and exploring clinical trials to give patients access to the latest treatments and improve their chances of prolonging survival.
Prognosis and Survival Rates
Sarcomatoid mesothelioma is the most aggressive and least treatable form of mesothelioma. Because it spreads rapidly and resists many standard treatments, the prognosis of this mesothelioma cell type is generally poor compared to that of other malignant mesothelioma subtypes.
However, early diagnosis, access to specialized care, and emerging treatments may help some patients with sarcomatoid tumors extend their survival and maintain a better quality of life.
The median survival rate for sarcomatoid mesothelioma is around 6 to 12 months after diagnosis.
Compared to epithelioid mesothelioma, which has a median survival of 18 to 24 months, sarcomatoid mesothelioma is more aggressive and harder to treat.
Since sarcomatoid cells spread faster and don’t respond as well to chemotherapy, survival rates are usually lower.
However, every case is different, and some patients have responded well to immunotherapy and clinical trials, potentially extending survival beyond initial estimates.
Several factors affect how long someone with sarcomatoid mesothelioma may survive:
Age & Overall Health – Younger, healthier patients often tolerate treatment better and may have a slightly longer survival time.
Stage at Diagnosis – Patients diagnosed at earlier stages (I or II) may live longer, while those diagnosed at stage IV typically have fewer treatment options.
Treatment Timing – Prompt access to specialized mesothelioma treatment can help slow progression.
Aggressiveness of the Cell Type – Sarcomatoid cells spread quickly, making it harder to surgically remove tumors or control them with chemotherapy.
While sarcomatoid mesothelioma is difficult to treat, palliative care plays an important role in managing symptoms and improving comfort.
Palliative treatments can:
Reduce pain and breathing difficulties caused by tumors.
Drain fluid buildup (pleural effusion) to relieve pressure in the lungs.
Support mental and emotional well-being through counseling, support groups, and holistic therapies.
Even if curative treatment isn’t an option, focusing on quality of life and symptom relief can significantly improve a patient’s daily well-being.
Prevention and Risk Reduction
Since sarcomatoid mesothelioma is almost always caused by asbestos exposure, the best way to prevent it is to limit contact with asbestos fibers—whether in the workplace, at home, or in the environment. Understanding asbestos regulations and safety measures can significantly reduce the risk.
People who work in construction, shipbuilding, manufacturing, and demolition are at the highest risk of asbestos exposure. To reduce the chances of inhaling or ingesting asbestos fibers, employers and workers must follow strict safety protocols, including:
Adhering to OSHA and EPA regulations that limit exposure levels in workplaces.
Wearing protective gear, like respirators and disposable coveralls, when working around asbestos.
Properly handling and disposing of asbestos materials to prevent airborne contamination.
Asbestos is not only an occupational hazard but can also be found in older homes, schools, and buildings.
It is necessary to identify asbestos-containing materials and take proper precautions when renovating or demolishing structures.
Common asbestos-containing materials include insulation, roofing, floor tiles, and cement.
Never disturb asbestos materials—cutting, drilling, or sanding them can release harmful fibers.
If asbestos is suspected, hire a licensed professional to test and safely remove it.
For more information on safe asbestos removal, resources like the EPA and local health departments offer guidelines and certified asbestos abatement services.
Taking these steps can help prevent exposure and lower the risk of developing mesothelioma and other asbestos-related diseases.
Patient Support and Resources
A sarcomatoid mesothelioma diagnosis can feel overwhelming, but patients and their families don’t have to face it alone.
Support groups, specialized treatment centers, and financial resources can provide guidance and relief during this challenging time.
Connecting with others who understand the struggles of mesothelioma can be incredibly helpful. Support groups provide a space to share experiences, gain advice, and find emotional encouragement.
Mesothelioma-specific communities: These focus on asbestos-related diseases and provide specialized guidance.
Online vs. in-person support: Online forums and virtual meetings offer flexibility, while local groups provide face-to-face interaction.
Organizations like the Mesothelioma Applied Research Foundation and Asbestos Disease Awareness Organization host support networks for patients and families.
Not all oncologists have experience treating sarcomatoid mesothelioma. Finding a specialist at a mesothelioma treatment center can significantly improve treatment outcomes.
Top mesothelioma specialists have experience with rare subtypes like sarcomatoid mesothelioma.
Major cancer centers, like MD Anderson Cancer Center, Brigham and Women’s Hospital, and the Mayo Clinic, offer cutting-edge treatments and clinical trials.
Counseling services help patients and families cope with the emotional toll of mesothelioma.
Legal and financial resources are available for those seeking compensation for asbestos exposure. Many mesothelioma law firms offer free case reviews to help patients understand their options.
FAQs About Sarcomatoid Mesothelioma
The primary cause is asbestos exposure.
When asbestos fibers are inhaled or ingested, they become trapped in the body, causing cellular damage and tumor development.
Sarcomatoid mesothelioma has a long latency period, meaning symptoms may not appear for as long as 20 to 50 years after exposure.
Early symptoms include persistent cough, chest pain, shortness of breath, and fatigue.
In advanced stages, symptoms worsen to include severe breathing difficulties, fluid buildup, and systemic complications.
Diagnosis involves imaging tests, such as CT and PET scans, to detect tumors.
A biopsy is necessary to confirm the presence of spindle-shaped sarcomatoid cells.
Yes, but treatment is challenging due to the aggressive nature of the disease.
Options include chemotherapy, immunotherapy, surgery (for eligible patients), and palliative care to manage symptoms.
Yes. Immunotherapy drugs like Keytruda and Opdivo are showing promise in improving survival rates.
Clinical trials continue to explore gene therapy and other experimental treatments for sarcomatoid mesothelioma.
Patients should discuss clinical trial opportunities with their medical team.
Support resources for sarcomatoid mesothelioma patients include:
Support groups: Local and online groups provide a platform for sharing experiences and receiving support.
Medical centers: Specialized cancer treatment centers offer comprehensive care and support services.
Non-profit organizations: Organizations like the Mesothelioma Applied Research Foundation and the American Cancer Society provide resources, information, and support.
Legal assistance: Mesothelioma Attorney offers legal support to help patients navigate the complexities of their case and secure compensation.
Free Case review
Fill out the form below and get your free case review
